4D Molecular Therapeutics Inc (FDMT)
10.83
-0.13
(-1.19%)
USD |
NASDAQ |
Sep 27, 16:00
10.84
0.00 (0.00%)
After-Hours: 20:00
4D Molecular Therapeutics Accounts Payable (Quarterly): 3.431M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 3.431M |
March 31, 2024 | 4.217M |
December 31, 2023 | 3.515M |
September 30, 2023 | 4.713M |
June 30, 2023 | 3.493M |
March 31, 2023 | 2.408M |
December 31, 2022 | 3.322M |
September 30, 2022 | 1.48M |
June 30, 2022 | 3.316M |
March 31, 2022 | 2.681M |
Date | Value |
---|---|
December 31, 2021 | 4.764M |
September 30, 2021 | 3.713M |
June 30, 2021 | 1.962M |
March 31, 2021 | 1.284M |
December 31, 2020 | 1.787M |
September 30, 2020 | 1.292M |
December 31, 2019 | 1.744M |
June 30, 2019 | 1.115M |
December 31, 2018 | 0.954M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.284M
Minimum
Mar 2021
4.764M
Maximum
Dec 2021
2.890M
Average
3.316M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
Johnson & Johnson | 8.848B |
Regeneron Pharmaceuticals Inc | 561.70M |
Journey Medical Corp | 14.60M |
NovaBay Pharmaceuticals Inc | 1.235M |
Palatin Technologies Inc | 3.443M |